SCIESCOPUSQ2
F&S Reports
ELSEVIER, United States
F&S Reports is an academic journal published by ELSEVIER (United States). Identifiers: eISSN 2666-3341. Indexed in SCIE, SCOPUS. Metrics: JIF 2.2, CiteScore 4.2, SJR 0.806, SNIP 0.89. tlooto lists 731 papers from this journal.
CiteScore
4.20
Scopus citation metric
SJR
0.806
SCImago rank
SNIP
0.89
Source normalized impact
Percentage rank
-
JIF percentile rank
Journal profile
- ISSN
- -
- eISSN
- 2666-3341
- Abbreviation
- F&S REP
- Publisher
- ELSEVIER
- Country
- United States
Web of Science categories
No Web of Science category data available.
Scopus ASJC categories
2710 Embryology2729 Obstetrics and Gynecology2743 Reproductive Medicine
Papers in this journal
Recent papers
- The follicle-stimulating hormone receptor unmasked: insights drawn from a case of spontaneous ovarian hyperstimulation syndrome
2026
- Comments on “Safety and pharmacology of AMY109, a long-acting anti–interleukin-8 antibody, for endometriosis: a double-blind, randomized phase 1 trial”
2026 · 1 citations
- Preserving possibilities: fertility after breast cancer treatment
2026
- First European live birth following uterine and adnexal transposition for fertility preservation: a case report and overview of reported neonatal outcomes
2026 · 1 citations
- Reproductive outcomes after fertility preservation using tamoxifen or letrozole in women with breast cancer: a long-term follow-up
2026
Most cited papers
- Use of contraception among reproductive-aged women in the United States, 2014 and 2016
2020 · 96 citations
- SARS-CoV-2 spike protein seropositivity from vaccination or infection does not cause sterility
2021 · 84 citations
- Disparities in access to fertility care: who’s in and who’s out
2020 · 66 citations
- Blastocyst score, a blastocyst quality ranking tool, is a predictor of blastocyst ploidy and implantation potential
2020 · 47 citations
- GnRH agonists in the treatment of symptomatic endometriosis: a review
2022 · 36 citations